1 |
Salem ML, Shoukry NM, Zidan, AA (2014a). Vournakis, J., Immunomodulatory effects of IL-12 released from poly-N-acetyl glucosamine gel matrix during schistosomiasis infection. Cytotechnol, 66, 667-75;
DOI
|
2 |
Vournakis JN, Demcheva M, Whitson A, Guirca R, Pariser ER (2004). Isolation, purification, and characterization of poly-N-acetyl glucosamine use as a hemostatic agent. J Trauma, 57, 2-6.
DOI
|
3 |
Salem ML, Attia WY, Al-Bolkiny YE, et al (2010b). Using poly-N-acetyl glucosamine gel matrix to deliver IL-12 with antischistosomasis vaccination. J Infect Dev Ctries, 4, 318-28.
|
4 |
Vournakis JN, Demcheva MV (2012). Compositions and methods for nanopolymer-based nucleic acid delivery. Google Patents.
|
5 |
Vournakis JN, Finkielsztein S, Pariser ER, Helton M (1997) Poly---4-N-acetylglucosamine. Google Patents: .
|
6 |
Bolhassani A, Safaiyan S, Rafati S (2011). Improvement of different vaccine delivery systems for cancer therapy. Mol Cancer, 10, 3.
|
7 |
Cole DJ, Gattoni-Celli S, McClay EF, et al (1997). Characterization of a sustained-release delivery system for combined cytokine/peptide vaccination using a poly-N-acetyl glucosamine-based polymer matrix. Clin Cancer Res, 3, 867-73.
|
8 |
Fischer TH, Thatte HS, Nichols TC, et al (2005). Synergistic platelet integrin signaling and factor XII activation in poly-N-acetyl glucosamine fiber-mediated hemostasis. Biomaterials, 26, 5433-43.
DOI
|
9 |
Kumar SS, Puttaraju HP (2012). Improvised microinjection technique for mosquito vectors. Indian J Med Res, 136, 971-8.
|
10 |
Liu SX, Xia ZS, Zhong,YQ (2014). Gene therapy in pancreatic cancer. World J Gastroenterol, 20, 13343-68.
DOI
|
11 |
Luo D, Saltzman WM (2000). Synthetic DNA delivery systems. Nat Biotechnol, 18, 33-7.
DOI
|
12 |
Maitre N, Brown JM, Demcheva M, et al (1999). Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination. Clin Cancer Res, 5, 1173-82.
|
13 |
Nayerossadat N, Maedeh T, Ali PA (2012). Viral and nonviral delivery systems for gene delivery. Adv Biomed Res, 1, 27.
DOI
|
14 |
Patil SD, Rhodes DG, Burgess DJ (2005). DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J, 7, 61-77.
DOI
|
15 |
Potter H, Heller R (2011). Transfection by electroporation. Curr Protoc Neurosci Appendix, 1, 1.
DOI
|
16 |
Rosenberg SA, Spiess P, Lafreniere R (1986). A new approach to the adoptive immunotherapy of cancer with tumorinfiltrating lymphocytes. Science, 233, 1318-21.
DOI
|